Lester RM, Paglialunga S, Johnson IA. QT assessment in early drug development: the long and the short of it. Int J Mol Sci. 2019;20(6):1324.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fernandes FM, Silva EP, Martins RR, Oliveira AG. QTc interval prolongation in critically ill patients: Prevalence, risk factors and associated medications. PLoS One. 2018;13(6):e0199028.

Article  PubMed  PubMed Central  Google Scholar 

Tisdale JE, Wroblewski HA, Overholser BR, et al. Prevalence of QT interval prolongation in patients admitted to cardiac care units and frequency of subsequent administration of QT interval-prolonging drugs: a prospective, observational study in a large urban academic medical center in the US. Drug Saf. 2012;35(6):459–70.

Article  CAS  PubMed  Google Scholar 

Armahizer MJ, Seybert AL, Smithburger PL, Kane-Gill SL. Drug-drug interactions contributing to QT prolongation in cardiac intensive care units. J Crit Care. 2013;28(3):243–9.

Article  PubMed  Google Scholar 

Hoogstraaten E, Rijkenberg S, van der Voort PH. Corrected QT-interval prolongation and variability in intensive care patients. J Crit Care. 2014;29(5):835–9.

Article  PubMed  Google Scholar 

Fernandes FM, da Silva Paulino AM, Sedda BC, et al. Assessment of the risk of QT-interval prolongation associated with potential drug-drug interactions in patients admitted to Intensive Care Units. Saudi Pharm J. 2019;27(2):229–34.

Article  PubMed  Google Scholar 

QT Drugs Lists. 2022. https://crediblemeds.org/druglist. Accessed 26 May 2022.

Strand DS, Kim D, Peura DA. 25 Years of proton pump inhibitors: a comprehensive review. Gut and liver. 2017;11(1):27–37.

Article  CAS  PubMed  Google Scholar 

Nehra AK, Alexander JA, Loftus CG, Nehra V. Proton pump inhibitors: review of emerging concerns. Mayo Clinic Proc. 2018;93(2):240–6.

Article  CAS  Google Scholar 

Moayyedi P, Leontiadis GI. The risks of PPI therapy. Nat Rev Gastroenterol Hepatol. 2012;9(3):132–9.

Article  CAS  PubMed  Google Scholar 

Savarino V, Marabotto E, Zentilin P, et al. Proton pump inhibitors: use and misuse in the clinical setting. Expert Rev Clin Pharmacol. 2018;11(11):1123–34.

Article  CAS  PubMed  Google Scholar 

Perazella MA. Proton pump inhibitors and hypomagnesemia: a rare but serious complication. Kidney Int. 2013;83(4):553–6.

Article  CAS  PubMed  Google Scholar 

Lazzerini PE, Bertolozzi I, Finizola F, et al. Proton pump inhibitors and serum magnesium levels in patients with torsades de pointes. Front Pharmacol. 2018;9:363.

Article  PubMed  PubMed Central  Google Scholar 

Hess MW, Hoenderop JG, Bindels RJ, Drenth JP. Systematic review: hypomagnesaemia induced by proton pump inhibition. Aliment Pharmacol Ther. 2012;36(5):405–13.

Article  CAS  PubMed  Google Scholar 

Bibawy JN, Parikh V, Wahba J, et al. Pantoprazole (proton pump inhibitor) contributing to torsades de Pointes storm. Circ Arrhythm Electrophysiol. 2013;6(2):e17–9.

Article  PubMed  Google Scholar 

Lazzerini PE, Cartocci A, Qu YS, et al. Proton pump inhibitors directly block hERG-potassium channel and independently increase the risk of QTc prolongation in a large cohort of US veterans. Circ Arrhythm Electrophysiol. 2021;14(7):e010042.

Article  CAS  PubMed  Google Scholar 

Rooney MR, Bell EJ, Alonso A, et al. Proton pump inhibitor use, hypomagnesemia and risk of cardiovascular diseases: the atherosclerosis risk in communities (ARIC) study. J Clin Gastroenterol. 2021;55(8):677–83.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Toews I, George AT, Peter JV, et al. Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units. Cochrane Database Syst Rev. 2018;6(6):CD008687. https://doi.org/10.1002/14651858.CD008687.pub2

Johnson AE, Pollard TJ, Shen L, et al. MIMIC-III, a freely accessible critical care database. Sci Data. 2016;3:160035.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12.

Article  PubMed  PubMed Central  Google Scholar 

George TK, Chase D, Peter JV, et al. Association between a prolonged corrected QT interval and outcomes in patients in a medical Intensive Care Unit. Indian J Crit Care Med. 2015;19(6):326–32.

Article  PubMed  PubMed Central  Google Scholar 

Drew BJ, Ackerman MJ, Funk M, et al. Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. Circulation. 2010;121(8):1047–60.

Article  PubMed  PubMed Central  Google Scholar 

Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med. 2004;350(10):1013–22.

Article  CAS  PubMed  Google Scholar 

Schwartz PJ, Woosley RL. Predicting the unpredictable: drug-induced QT prolongation and torsades de pointes. J Am Coll Cardiol. 2016;67(13):1639–50.

Article  PubMed  Google Scholar 

El-Charabaty E, Saifan C, Abdallah M, et al. Effects of proton pump inhibitors and electrolyte disturbances on arrhythmias. Int J Gen Med. 2013;6:515–8.

PubMed  PubMed Central  Google Scholar 

Lorberbaum T, Sampson KJ, Chang JB, et al. Coupling data mining and laboratory experiments to discover drug interactions causing QT prolongation. J Am Coll Cardiol. 2016;68(16):1756–64.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tasci O, Kiran TE. Does the use of proton pump inhibitors in children affect ventricular repolarisation parameters? Cardiol Young. 2022;2:1–5.

Google Scholar 

Wolfes J, Ellermann C, Burde S, et al. Concomitant treatment with proton pump inhibitors and cephalosporins does not enhance QT-associated proarrhythmia in isolated rabbit hearts. Cardiovasc Toxicol. 2020;20(6):531–8.

Article  CAS  PubMed  Google Scholar 

Malihi G, Nikoui V, Elson EL. A review on qualifications and cost effectiveness of induced pluripotent stem cells (IPSCs)-induced cardiomyocytes in drug screening tests. Arch Physiol Biochem. 2020;1–12.

Kang J, Wang L, Chen XL, Triggle DJ, Rampe D. Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG. Mol Pharmacol. 2001;59(1):122–6.

Article  CAS  PubMed  Google Scholar 

Guo J, Zhan S, Lees-Miller JP, Teng G, Duff HJ. Exaggerated block of hERG (KCNH2) and prolongation of action potential duration by erythromycin at temperatures between 37 degrees C and 42 degrees C. Heart Rhythm. 2005;2(8):860–6.

Article  PubMed  Google Scholar 

Teschemacher AG, Seward EP, Hancox JC, Witchel HJ. Inhibition of the current of heterologously expressed HERG potassium channels by imipramine and amitriptyline. Br J Pharmacol. 1999;128(2):479–85.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Glassman AH, Bigger JT Jr. Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death. Am J Psychiatry. 2001;158(11):1774–82.

Article  CAS  PubMed  Google Scholar 

Zünkler BJ, Wos-Maganga M. Comparison of the effects of methadone and heroin on human ether-à-go-go-related gene channels. Cardiovasc Toxicol. 2010;10(3):161–5.

Article  PubMed  Google Scholar 

Kuryshev YA, Brown AM, Wang L, Benedict CR, Rampe D. Interactions of the 5-hydroxytryptamine 3 antagonist class of antiemetic drugs with human cardiac ion channels. J Pharmacol Exp Ther. 2000;295(2):614–20.

CAS  PubMed  Google Scholar 

Claassen S, Zünkler BJ. Comparison of the effects of metoclopramide and domperidone on HERG channels. Pharmacology. 2005;74(1):31–6.

Article  CAS  PubMed  Google Scholar 

Asajima H, Saito N, Ohmura Y, Ohmura K. Lansoprazole precipitated QT prolongation and torsade de pointes associated with disopyramide. Eur J Clin Pharmacol. 2012;68(3):331–3.

Article  PubMed  Google Scholar 

Assimon MM, Pun PH, Al-Khatib SM, et al. Proton pump inhibitors may enhance the risk of citalopram- and escitalopram-associated sudden cardiac death among patients receiving hemodialysis. Pharmacoepidemiol Drug Saf. 2022;31(6):670–9.

Article  PubMed  PubMed Central  Google Scholar 

Khan Q, Ismail M, Haider I, Ali Z. Prevalence of the risk factors for QT prolongation and associated drug-drug interactions in a cohort of medical inpatients. J Formos Med Assoc. 2019;118:109–15.

Article  PubMed  Google Scholar 

Ye Z, Reintam Blaser A, Lytvyn L, et al. Gastrointestinal bleeding prophylaxis for critically ill patients: a clinical practice guideline. BMJ. 2020;368:l6722.

Article  PubMed  Google Scholar